LightNews
David-Alexandre TRÉGOUËT
@tregouetbph.bsky.social
31 followers 27 following 3 posts
Director of the Molecular Epidemiology of Vascular and Brain Disorders team at Bordeaux Population Health Research center, INSERM, France. 'Success is the ability to go from one failure to another with no loss of enthusiasm'. W. C
Posts Media Videos Starter Packs
David-Alexandre TRÉGOUËT @tregouetbph.bsky.social · Aug 15
What better way to celebrate the 10th anniversary of the first meta-GWAS on VTE than with the acceptance of the first meta-GWAS on recurrence?
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.
Munsch G, et al. . Blood. 2025 ahead of print. PMID: 40811855
David-Alexandre TRÉGOUËT @tregouetbph.bsky.social · Dec 3
New Genomic Discoveries Pave the Way for Research into Predictive thrombosis recurrence Factors and Innovative Preventive Strategies
David-Alexandre TRÉGOUËT @tregouetbph.bsky.social · Feb 10
First manuscript of my PhD student Blandine Gendre. New molecular player in factor V regulation identified by a underestimated statistical method for GWAS data
biorxiv-genetic.bsky.social
bioRxiv Genetics @biorxiv-genetic.bsky.social · Feb 9
A genome wide search for non-additive allele effects identifies PSKH2 as involved in the variability of Factor V activity. https://www.biorxiv.org/content/10.1101/2024.02.08.579474v1
A genome wide search for non-additive allele effects identifies PSKH2 as involved in the variability of Factor V activity. https://www.biorxiv.org/content/10.1101/2024.02.08.579474v1
Factor V (FV) is a key molecular player in the coagulation cascade. FV plasma levels have been assoc
www.biorxiv.org
1 2